Product Information
PSEUDOEPHEDRINE ER 120 MG TAB is a generic product labeled by Major Pharmaceuticals, priced at $0.2811 per EA under NDC 00904740915. Its NADAC has been published 111 times since Aug 21, 2024.
FDA first approved this application on Sep 28, 2005.
The Low Outlier badge above means this manufacturer's average price in the Pseudoephedrine hydrochloride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
120 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904740915
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077442FDA Approved
9/28/2005
On Market Since
6/7/2024
Pharmacological Classes
Price Statistics
The NADAC for PSEUDOEPHEDRINE ER 120 MG TAB has been published 111 times since Aug 21, 2024, and over the history we have for it it has declined 9.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2811 per EA |
|---|---|
| All-time high | $0.3107 (Sep 11, 2024) |
| All-time low | $0.2621 (Nov 19, 2025) |
| 52-week high | $0.2869 |
| 52-week low | $0.2621 |
| Median price | $0.2787 |
| Average price | $0.2792 |
| Largest weekly change | -8.8% (Sep 18, 2024) |
| Weeks tracked | 111 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pseudoephedrine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PSEUDOEPHEDRINE ER 120 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PSEUDOEPHEDRINE ER 120 MG TAB, manufactured by Major Pharmaceuticals, is $0.2811 per EA (NDC 00904740915), effective Sep 30, 2026.
How has the price of PSEUDOEPHEDRINE ER 120 MG TAB changed over time?
Over the history we have for it, the NADAC for PSEUDOEPHEDRINE ER 120 MG TAB has declined 9.5%. It has been tracked across 111 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for PSEUDOEPHEDRINE ER 120 MG TAB?
Since Aug 21, 2024, the NADAC for PSEUDOEPHEDRINE ER 120 MG TAB has ranged from a low of $0.2621 (Nov 19, 2025) to a high of $0.3107 (Sep 11, 2024), with a median of $0.2787 per EA.
Are there cheaper alternatives to PSEUDOEPHEDRINE ER 120 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PSEUDOEPHEDRINE ER 120 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures PSEUDOEPHEDRINE ER 120 MG TAB?
PSEUDOEPHEDRINE ER 120 MG TAB (NDC 00904740915) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.